Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs

Alyson Haslam; Jennifer Gill; Vinay Prasad

doi:10.1001/jamanetworkopen.2020.0423

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs

Alyson Haslam, Jennifer Gill, Vinay Prasad

Knight Cancer Institute

Research output: Contribution to journal › Article › peer-review

137 Scopus citations

Original language	English (US)
Pages (from-to)	e200423
Journal	JAMA Network Open
Volume	3
Issue number	3
DOIs	https://doi.org/10.1001/jamanetworkopen.2020.0423
State	Published - Mar 2 2020

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jamanetworkopen.2020.0423

Cite this

@article{a62903311d5547798db33ecfbb35c110,

title = "Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs",

author = "Alyson Haslam and Jennifer Gill and Vinay Prasad",

year = "2020",

month = mar,

day = "2",

doi = "10.1001/jamanetworkopen.2020.0423",

language = "English (US)",

volume = "3",

pages = "e200423",

journal = "JAMA Network Open",

issn = "2574-3805",

publisher = "American Medical Association",

number = "3",

}

TY - JOUR

T1 - Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs

AU - Haslam, Alyson

AU - Gill, Jennifer

AU - Prasad, Vinay

PY - 2020/3/2

Y1 - 2020/3/2

UR - http://www.scopus.com/inward/record.url?scp=85081635477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081635477&partnerID=8YFLogxK

U2 - 10.1001/jamanetworkopen.2020.0423

DO - 10.1001/jamanetworkopen.2020.0423

M3 - Article

C2 - 32150268

SN - 2574-3805

VL - 3

SP - e200423

JO - JAMA Network Open

JF - JAMA Network Open

IS - 3

ER -

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this